Ocular Therapeutix (OCUL)

Common Shares

Sell: $12.16|Buy: $12.18|Change: 0.34 (2.87%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Company profile

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Address

24 Crosby Drive
Bedford
MA
USA
01730

Telephone

+1 877 6288998

Website

https://www.ocutx.com

Sector

Healthcare

Forecast key dates

Name	Key Date
Ocular Therapeutix Inc Second Quarter Earnings Conference Call for 2026	2026-08-05T08:00:00
Ocular Therapeutix Inc Second Quarter Earnings Results for 2026	2026-08-05T00:00:00
Ocular Therapeutix Inc Annual General Meeting for 2026	2026-06-11T08:30:00
Ocular Therapeutix Inc First Quarter Earnings Results for 2026	2026-05-05T07:00:00
Ocular Therapeutix Inc Fourth Quarter Earnings Conference Call for 2025	2026-03-03T08:00:00
Ocular Therapeutix Inc Fourth Quarter Earnings Results for 2025	2026-03-03T00:00:00
Ocular Therapeutix Inc Annual Report for 2025	2026-03-03T00:00:00
Ocular Therapeutix Inc Third Quarter Earnings Conference Call for 2025	2025-11-14T08:00:00
Ocular Therapeutix Inc Third Quarter Earnings Results for 2025	2025-11-14T00:00:00

Previous key dates

Name	Key Date
Investor Day 2025	2025-09-30T14:00:00
Ocular Therapeutix, Inc. Baird 2025 Global Healthcare Conference	2025-09-09T12:50:00
Ocular Therapeutix, Inc. Morgan Stanley 23rd Annual Global Healthcare Conference 2025	2025-09-08T14:35:00
Ocular Therapeutix Inc Second Quarter Earnings Conference Call for 2025	2025-08-05T08:00:00
Ocular Therapeutix Inc Second Quarter Earnings Result for 2025	2025-08-05T00:00:00
Ocular Therapeutix Inc Annual General Meeting for 2025	2025-06-11T08:30:00
Bank of America 2025 Global Healthcare Conference	2025-05-13T09:00:00
Citizens JMP Life Sciences Conference 2025	2025-05-07T09:00:00
Ocular Therapeutix Inc First Quarter Earnings Results for 2025	2025-05-05T07:00:00
24th Annual Needham Virtual Healthcare Conference	2025-04-07T15:00:00
Leerink Partners Global Healthcare Conference 2025	2025-03-10T10:00:00
TD Cowen 45th Annual Health Care Conference	2025-03-04T11:50:00
Ocular Therapeutix Inc Fourth Quarter Earnings Conference Call for 2024	2025-03-03T08:00:00
Ocular Therapeutix Inc Fourth Quarter Earnings Result for 2024	2025-03-03T00:00:00
Ocular Therapeutix Inc Annual Report for 2024	2025-03-03T00:00:00
43rd Annual J.P. Morgan Healthcare Conference	2025-01-13T17:15:00
Piper Sandler 36(th) Annual Healthcare Conference	2024-12-03T13:30:00
Jefferies London Healthcare Conference 2024	2024-11-20T09:00:00
Ocular Therapeutix Inc Third Quarter Earnings Conference Call for 2024	2024-11-14T08:00:00
Ocular Therapeutix Inc Third Quarter Earnings Result for 2024	2024-11-14T00:00:00
UBS Virtual Opthalmology Day 2024	2024-10-02T15:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.